Cargando…
Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
BACKGROUND: Cell-targeting peptides or proteins are appealing tools in nanomedicine and innovative medicines because they increase the local drug concentration and reduce potential side effects. CXC chemokine receptor 4 (CXCR4) is a cell surface marker associated with several severe human pathologie...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423154/ https://www.ncbi.nlm.nih.gov/pubmed/22923991 http://dx.doi.org/10.2147/IJN.S34450 |